Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the ...

This was the stock's second consecutive day of losses.

Healthcare giant Pfizer ( PFE 2.24%) has been offering a high yield for some time. But that hasn't been enough to get ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

Pfizer eventually increased its offer. The company is now set to acquire Metsera in a deal worth up to $10 billion, including ...

Pfizer (PFE) shares have shown resilience, with a modest uptick over the past week and month. Investors are keeping an eye on ...

Pfizer offers strong dividends, solid cash flow coverage, discounted value and key risks from patent cliffs, pricing and ...

Pfizer PFE stock has been trading above its 50-day moving average since early November, indicating a potential short-term ...

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

When the AI bubble bursts, Altria will look like a pretty good investment again. It has paid out billions in dividends over ...

OLMA stock surged 197% after Roche’s SERD breakthrough, signaling investor conviction in the future of ER-positive breast ...

Sudeep Pharma serves over 1,100 customers, including Pfizer Inc, Mankind Pharma, Merck Group, Aurobindo Pharma, Cadila ...